These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 10491525)

  • 1. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
    Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
    Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult lymph node metastases in early stage vulvar carcinoma patients.
    Knopp S; Holm R; Tropé C; Nesland JM
    Gynecol Oncol; 2005 Nov; 99(2):383-7. PubMed ID: 16051338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
    Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
    Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
    Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients.
    Viale G; Bosari S; Mazzarol G; Galimberti V; Luini A; Veronesi P; Paganelli G; Bedoni M; Orvieto E
    Cancer; 1999 Jun; 85(11):2433-8. PubMed ID: 10357414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.
    Fréneaux P; Nos C; Vincent-Salomon A; Genin P; Sigal-Zafrani B; Al Ghuzlan A; Birolini MJ; Clough K; Sastre-Garau X
    Mod Pathol; 2002 Jun; 15(6):641-6. PubMed ID: 12065778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult metastases in sentinel nodes of 200 patients with operable breast cancer.
    Dowlatshahi K; Fan M; Anderson JM; Bloom KJ
    Ann Surg Oncol; 2001 Sep; 8(8):675-81. PubMed ID: 11569784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraoperative evaluation of axillary lymph nodes for micrometastases using immunohistochemistry--preliminary study].
    Sawada T; Sakurada M; Hasegawa Y; Kobayashi M
    Rinsho Byori; 2003 Jun; 51(6):522-7. PubMed ID: 12884738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.
    Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH
    Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.
    Amir AS; Azar FP; Sahram N; Naser FM; Na'ma MR; Farid F; Khatoon AN; Ramin S; Ali TK
    Pol J Pathol; 2012 Mar; 63(1):40-4. PubMed ID: 22535605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
    Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
    Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
    Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
    Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.